P. Zelini

发表

Nuclear mRNA retention and aberrant doppel protein expression in human astrocytic tumor cells.

L. Chiarelli, A. Azzalin, S. Comincini, 2006, Oncology reports.

Human Leukocyte Antigen and Antigen Processing Machinery Component Defects in Astrocytic Tumors

S. Ferrone, P. Morbini, A. Facoetti, 2005, Clinical Cancer Research.

Serum and breastmilk SARS-CoV-2 specific antibodies following BNT162b2 vaccine: prolonged protection from SARS-CoV-2 in newborns and older children

F. Baldanti, A. de Silvestri, M. Colaneri, 2022, International Journal of Infectious Diseases.

Human cytomegalovirus-specific CD4(+) and CD8(+) T-cell response determination: comparison of short-term (24h) assays vs long-term (7-day) infected dendritic cell assay in the immunocompetent and the immunocompromised host.

D. Lilleri, G. Gerna, F. Locatelli, 2010, Clinical immunology.

Human cytomegalovirus (HCMV)‐specific T cell but not neutralizing or IgG binding antibody responses to glycoprotein complexes gB, gHgLgO, and pUL128L correlate with protection against high HCMV viral load reactivation in solid‐organ transplant recipients

D. Lilleri, G. Gerna, C. Fornara, 2018, Journal of medical virology.

Association between Vitamin D Serum Levels and Immune Response to the BNT162b2 Vaccine for SARS-CoV-2

D. Lilleri, E. Cereda, C. Klersy, 2022, Biomedicines.

Human cytomegalovirus non-primary infection during pregnancy: antibody response, risk factors and newborn outcome.

M. Furione, D. Lilleri, A. Arossa, 2021, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Determination of anti-p52 IgM and anti-gB IgG by ELISA as a novel diagnostic tool for detection of early and late phase of primary human cytomegalovirus infections during pregnancy.

M. Furione, D. Lilleri, A. Arossa, 2019, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Human Cytomegalovirus (HCMV)-Specific CD4+ and CD8+ T Cells Are Both Required for Prevention of HCMV Disease in Seropositive Solid-Organ Transplant Recipients

M. Furione, D. Lilleri, G. Gerna, 2014, PloS one.

Immunological Aspects of Human Papilloma Virus-Related Cancers Always Says, “I Am like a Box of Complexity, You Never Know What You Are Gonna Get”

F. Baldanti, B. Gardella, I. Cassaniti, 2022, Vaccines.

Follicular helper T-cells and virus-specific antibody response in primary and reactivated human cytomegalovirus infections of the immunocompetent and immunocompromised transplant patients.

F. Sallusto, M. Furione, D. Lilleri, 2016, The Journal of general virology.

Role of human cytomegalovirus (HCMV)-specific antibody in HCMV-infected pregnant women.

D. Lilleri, A. Arossa, C. Fornara, 2014, Early human development.

SARS‐CoV‐2 serology in patients on biological therapy or apremilast for psoriasis: a study of 93 patients in the Italian red zone

D. Lilleri, C. Vassallo, V. Brazzelli, 2021, Journal of the European Academy of Dermatology and Venereology : JEADV.

Monitoring of Human Cytomegalovirus and Virus-Specific T-Cell Response in Young Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation

D. Lilleri, G. Gerna, A. Mastronuzzi, 2012, PloS one.

Inconsistent Responses of Cytomegalovirus‐Specific T Cells to pp65 and IE‐1 versus Infected Dendritic Cells in Organ Transplant Recipients

D. Lilleri, G. Gerna, C. Fornara, 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Virologic and Immunologic Monitoring of Cytomegalovirus to Guide Preemptive Therapy in Solid‐Organ Transplantation

E. Arbustini, M. Furione, D. Lilleri, 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Detection of Epstein–Barr virus‐specific memory CD4+ T cells using a peptide‐based cultured enzyme‐linked immunospot assay

F. Baldanti, S. Calarota, L. Minoli, 2013, Immunology.

Differential Kinetics of Effector and Memory Responses Induced by Three Doses of SARS-CoV-2 mRNA Vaccine in a Cohort of Healthcare Workers

F. Baldanti, D. Lilleri, E. Percivalle, 2022, Vaccines.

Kinetics of T-Lymphocyte Subsets and Posttransplant Opportunistic Infections in Heart and Kidney Transplant Recipients

F. Baldanti, C. Tinelli, A. de Silvestri, 2012, Transplantation.

Harnessing T Cells to Control Infections After Allogeneic Hematopoietic Stem Cell Transplantation

M. Luppi, S. Basso, Stella Boghen, 2020, Frontiers in Immunology.

Management of PTLD After Hematopoietic Stem Cell Transplantation: Immunological Perspectives

F. Baldanti, L. Stoppini, S. Basso, 2020, Frontiers in Immunology.

Reconstitution of Human Cytomegalovirus-Specific CD4+ T Cells is Critical for Control of Virus Reactivation in Hematopoietic Stem Cell Transplant Recipients but Does Not Prevent Organ Infection.

M. Furione, D. Lilleri, G. Gerna, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

SARS-CoV-2 mRNA vaccine BNT162b2 elicited a robust humoral and cellular response against SARS-CoV-2 variants.

F. Baldanti, L. Varani, D. Lilleri, 2021 .

Human cytomegalovirus-specific CD4+ and CD8+ T cell responses in primary infection of the immunocompetent and the immunocompromised host.

D. Lilleri, G. Gerna, C. Fornara, 2009, Clinical immunology.

Robust and Persistent B- and T-Cell Responses after COVID-19 in Immunocompetent and Solid Organ Transplant Recipient Patients

F. Baldanti, A. Di Matteo, D. Lilleri, 2021, Viruses.

Comparison of the T-cell response to human cytomegalovirus (HCMV) as detected by cytokine flow cytometry and QuantiFERON-CMV assay in HCMV-seropositive kidney transplant recipients.

D. Lilleri, G. Gerna, T. Rampino, 2018, The new microbiologica.

Predictive value of human cytomegalovirus (HCMV) T-cell response in the control of HCMV infection by seropositive solid-organ transplant recipients according to different assays and stimuli.

D. Lilleri, G. Gerna, F. Mangione, 2016, The new microbiologica.

Humoral and cell-mediated response against SARS-CoV-2 variants elicited by mRNA vaccine BNT162b2 in healthcare workers: a longitudinal observational study

F. Baldanti, L. Varani, D. Lilleri, 2021, Clinical Microbiology and Infection.

Dynamics of humoral and cellular immunity elicited by the BNT162b2 mRNA vaccine in psoriatic patients under targeted immunosuppression: A longitudinal cohort study

F. Baldanti, D. Lilleri, C. Klersy, 2022, Journal of the European Academy of Dermatology and Venereology : JEADV.

Inflammatory and Immune Responses during SARS-CoV-2 Infection in Vaccinated and Non-Vaccinated Pregnant Women and Their Newborns

F. Baldanti, D. Lilleri, P. Sainaghi, 2023, Pathogens.

Yet another in vitro evidence that natural compounds introduced by diet have anti-amyloidogenic activities and can counteract neurodegenerative disease depending on aging.

M. Iriti, A. Pascale, S. Vitalini, 2023, Natural product research.

Detection of Epstein–Barr virus‐specific memory CD4+ T cells using a peptide‐based cultured enzyme‐linked immunospot assay

F. Baldanti, S. Calarota, L. Minoli, 2013, Immunology.

Reconstitution of Human Cytomegalovirus-Specific CD4+ T Cells is Critical for Control of Virus Reactivation in Hematopoietic Stem Cell Transplant Recipients but Does Not Prevent Organ Infection.

M. Furione, D. Lilleri, G. Gerna, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Impact of SARS-CoV-2 infection during pregnancy and persistence of antibody response.

F. Baldanti, D. Lilleri, A. Arossa, 2022, The new microbiologica.

Evaluation of the In Vitro Capacity of Anti-Human Cytomegalovirus Antibodies to Initiate Antibody-Dependent Cell Cytotoxicity

F. Baldanti, D. Lilleri, C. Fornara, 2024, Microorganisms.